NMNH, or β-nicotinamide mononucleotide, is the reduced form of NMN and a highly effective precursor to NAD+, the essential coenzyme involved in numerous metabolic processes. Unlike NMN, BONTAC‘s NMNH can be rapidly converted into NAD+ within cells, resulting in a more than 2-fold increase in the rate and concentration of NAD+ compared to NMN. This makes such NMNH a superior choice for boosting energy levels and supporting overall cellular function.

NMNH Specifications and Purity

BONTAC’s NMNH powder boasts an exceptional purity of 99.5% or higher, making it one of the most potent and reliable NMNH products on the market. The powder has a yellowish appearance and a specified sodium content ranging from 10% to 14%, with a water content of 8% or less. BONTAC ensures the product’s pH remains within the optimal range of 7.0 to 10.0, and it is thoroughly tested to be free of heavy metal contaminants and microbiological impurities.

BONTAC’s Pioneering Approach

BONTAC is proud to be the world’s first company to achieve large-scale production of NMNH. This remarkable feat is a testament to the company’s innovative capabilities and commitment to advancing the field of NAD+ enhancement. BONTAC’s leading enzymatic process ensures the highest quality and purity of its NMNH powder, setting the standard for the industry.

Versatile Product Offerings

BONTAC’s NMNH product is available in both free acid and sodium salt forms, catering to the diverse needs and preferences of its customers. This flexibility allows BONTAC to provide tailored solutions to meet the specific requirements of various applications, ranging from dietary products to biomedical research.

Conclusion

BONTAC’s NMNH powder stands out in the market due to its unparalleled quality, purity, and innovative production methods. The company’s pioneering approach to large-scale NMNH manufacturing, combined with its stringent quality control measures, ensures that BONTAC’s NMNH products are consistently reliable, potent, and safe for use. This competitive edge solidifies BONTAC’s position as a trusted leader in the NMNH and NAD+ enhancement industry.